Effect of Denosumab on bone mineral density and incident fractures in primary hyperparathyroidism older women not underwent surgery

Trial Profile

Effect of Denosumab on bone mineral density and incident fractures in primary hyperparathyroidism older women not underwent surgery

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2018

At a glance

  • Drugs Denosumab (Primary)
  • Indications Osteoporosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Jan 2018 New trial record
    • 24 Jan 2018 Results published in the Journal of the American Geriatrics Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top